Notice of call and Agenda
Shareholders’ documentation

 

  Quorum, agreements and Votes - Only available in Spanish

 Agreements

    Proposed resolutions submitted by the Board of Directors to the decision of the General Shareholders Meeting

    Individual Annual Financial Statements of Pharma Mar, S.A., Management Report, and relevant audit report corresponding to year 2018

    Annual Financial Statements of the Consolidated Group, the Group's Management Report, the separate Report related to the Non-Financial Information State of the Group that forms part of the Group's Management Report, and the Auditor's Report for the year 2018

    Identity, curriculum and category of the Directors whose appointment or re-election is proposed to the General Meeting under item Three of the Agenda - only available in Spanish

    Report of the Appointments and Compensation Committee justifying the proposals of the Board of Directors of the Company for the re-election of non-independent Directors under item Three of the Agenda - only available in Spanish

    Proposal of the Appointments and Compensation Committee to the Board of Directors for the appointment and re-election of independent Directors under item Three of the Agenda - only available in Spanish

    Report formulated by the Board of Directors in relation to the proposals for the appointment and re-election of Directors under item Three of the Agenda - only available in Spanish

    Annual Corporate Governance Report for fiscal year 2018

    Annual Report on Directors' Compensation for fiscal year 2018

    The Audit Committee's Report on independence of the external auditor - only available in Spanish

    2018 Operating Report by Audit Committee - only available in Spanish

    2018 Operating Report by the Appointments and Compensation Committee - only available in Spanish

    The Report of the Board of Directors of Pharma Mar, S.A. relating to the sale of Zelnova Zeltia, S.A. in favor of an investor group composed of, among others, Mr. Pedro Fernández Puentes, Director of Pharma Mar, S.A., and persons related to him - only available in Spanish

    The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - only available in Spanish

Right to information

 

    Right to information - only available in Spanish

                            Link Right to Information - only available in Spanish

Attendance, Proxy and distance voting card

 

    Attendance, Proxy and distance voting card - only available in Spanish

Online voting delegation/ Shareholders representation at General Shareholders Meeting

 

    Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish

                            On-line Voting delegation - only available in Spanish

Electronic Shareholder Forum

 

    Regulations on electronic shareholder forum - only available in Spanish

                            Electronic Sharehoder Forum - only available in Spanish

General Shareholders’ meeting broadcasting

                        General Shareholders’ meeting broadcasting

Notice of call and Agenda
Shareholders’ documentation

 

  Quorum, agreements and Votes - Only available in Spanish

 Agreements - Only available in Spanish

 Proposed resolutions submitted by the Board of Directors to the decision of the General Shareholders Meeting

 Annual Financial Statements and Management Reports of Pharma Mar, S.A. and its consolidated group for fiscal year ending 31 December 2017, together with the relevant audit reports

 Identity, curriculum and category of the Directors whose appointment and or re-election is proposed to the General Meeting under item Three of the Agenda - Only available in Spanish

 Report of the Appointments and Compensation Committee justifying the proposals of the Board of Directors of the Company for the re-election of non-independent Directors under item Three of the Agenda - Only available in Spanish

 Proposal of the Appointments and Compensation Committee to the Board of Directors for the appointment and re-election of independent Directors under item Three of the Agenda - Only available in Spanish

 Report formulated by the Board of Directors in relation to the proposals for the appointment and re-election of Directors under item Three of the Agenda - Only available in Spanish

 Annual Corporate Governance Report for fiscal year 2017

 Annual Report on Directors’ Compensation for fiscal year 2017

 Appointments and Compensation Committee Report on the proposal for Pharma Mar, S.A.’s Directors’ Compensation Policy for 2019-2021- Only available in Spanish

 Pharma Mar, S.A.’s Directors’ Compensation Policy for 2019-2021

 The Audit Committee’s Report on independence of the external auditor - Only available in Spanish

 2017 Operating Report by Audit Committee - Only available in Spanish

 2017 Operating  Report by the Appointments and Compensation Committee - Only available in Spanish

 2017 corporate social responsibility report for the Pharma Mar Group

 The amendments made to the Regulations of the Board of Directors of Pharma Mar, S.A. since the last General Meeting - Only available in Spanish

 The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - Only available in Spanish

Attendance, Proxy and distance voting card
General Shareholders' meeting broadcasting
Notice of call and Agenda
Shareholders’ documentation

 

   Quorum, agreements and Votes - Only available in Spanish

  Agreements - Only available in Spanish

  Proposed resolutions submitted by the Board of Directors to the decision of the General Shareholders Meeting

  Annual Financial Statements and Management Reports of Pharma Mar, S.A. and its consolidated group for fiscal year ending 31 December 2016, together with the relevant audit reports

  Directors’ report on Agenda Item Three - Only available in Spanish

   Directors’ report on Agenda Item Four - Only available in Spanish

  Annual Corporate Governance Report for fiscal year 2016

   Annual Report on Directors’ Compensation for fiscal year 2016

   The Audit Committee’s Report on independence of the external auditor - Only available in Spanish

  2016 Operating Report by Audit Committee - Only available in Spanish

  2016 corporate social responsibility report for the Pharma Mar Group

  The amendments made to the Regulations of the Board of Directors of Pharma Mar, S.A. since the last General Meeting
Only available in Spanish

  Directors’ reports and audit report, issued by a statutory auditor other than the Company’s auditor and designated by the Mercantile Registry, in relation to the capital increases with exclusion of preemptive subscription rights agreed to by the Board of Directors on 17 May 2017, in exercise of the powers granted thereto, by virtue of Agenda Resolution Eleven of the Company’s General Meeting held on 30 June 2015, to increase share capital - Only available in Spanish

   The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice
Only available in Spanish

   

Attendance, Proxy and distance voting card
General Shareholders' meeting broadcasting
Notice of call and Agenda
Attendance, Proxy and distance voting card
General Shareholders' meeting broadcasting
Notice of call and Agenda
Shareholders’ documentation

 

   Quorum, agreements and Votes - Only available in Spanish

  Agreements - Only available in Spanish

   Annual Accounts and management report (31/12/2014) individual and consolidated accounts, with the respective report presented by the auditor - Only available in Spanish

   Report presented by the board of directors in relation to the amendments to the Company’s bylaws (Item Three of the Agenda) - Only available in Spanish

  Report presented by the board of directors in relation to the amendments to the General Meeting Rules (Item Four of the Agenda) - Only available in Spanish

   Identity and curriculum of the directors whose reappointment is proposed to the General Meeting under Item five of the Agenda (and in the case of director corporate body, the same information in relation to the individual who is to be appointed for exercising its functions), including the category to which they belong and the proposals (Download PDF) and reports referred to in Article 529 decies of the Spanish Corporate Enterprises Act (Download PDF) - Only available in Spanish

  Report presented by the board of directors in relation to the amendments to the Board of Director Rules (Item Nine of the Agenda) - Only available in Spanish

  Report presented by the board of directors on the use made of the power delegated by the General Shareholders’ Meeting of June 12, 2013 concerning the issuance of bonds (Item Ten of the Agenda) - Only available in Spanish

  Annual corporate governance report 2014 - Only available in Spanish

  Annual Report on the Zeltia Director’s Remuneration 2014 - Only available in Spanish

   Total number of shares and voting rights on the date of call to the General Shareholders Meeting - Only available in Spanish

  Joint Merger Plan of Zeltia, S.A., as absorbed Company, and Pharma Mar S.A. Sociedad Unipersonal, as absorbing company - Only available in Spanish

   Annual Accounts and management report individual of Zeltia, S.A. and consolidated accounts for the years ending on 31 December 20122013 and 2014, with the corresponding reports presented by the auditor - Only available in Spanish

   Annual Accounts and management report individual of Pharma Mar S.A., Sociedad Unipersonal for the years ending on 31 December 20122013 and 2014, with the corresponding reports presented by the auditor - Only available in Spanish

  Merger balance sheet of Zeltia, S.A., which corresponds with the latest annual balance sheet reported as of 31 December 2014, with the respective report presented by the auditor - Only available in Spanish

  Merger balance sheet of Pharma Mar S.A., Sociedad Unipersonal, which corresponds with the latest annual balance sheet reported as of 31 December 2014, with the respective report presented by the auditor - Only available in Spanish

  Current bylaws of Zeltia, S.A. along with the text resulting from the bylaws for the case they have been adopted the amendments proposed to the General Meeting under Item Three of the Agenda - Only available in Spanish

  Current bylaws of Pharma Mar, S.A. Sociedad Unipersonal along with the text of the new bylaws of Pharma Mar, S.A. Sociedad Unipersonal including the amendments to be introduced - Only available in Spanish

  Identity of the board members of Zeltia, S.A. and Pharma Mar, S.A. Sociedad Unipersonal, and the date on which they took their positions, and, where appropriate, the same indications of those who will be proposed as directors as a result of the merger - Only available in Spanish

Shareholders representation at the General Shareholders Meeting
Attendance, Proxy and voting card
2019
Notice of call and Agenda
Shareholders’ documentation

 

  Quorum, agreements and Votes - Only available in Spanish

 Agreements

    Proposed resolutions submitted by the Board of Directors to the decision of the General Shareholders Meeting

    Individual Annual Financial Statements of Pharma Mar, S.A., Management Report, and relevant audit report corresponding to year 2018

    Annual Financial Statements of the Consolidated Group, the Group's Management Report, the separate Report related to the Non-Financial Information State of the Group that forms part of the Group's Management Report, and the Auditor's Report for the year 2018

    Identity, curriculum and category of the Directors whose appointment or re-election is proposed to the General Meeting under item Three of the Agenda - only available in Spanish

    Report of the Appointments and Compensation Committee justifying the proposals of the Board of Directors of the Company for the re-election of non-independent Directors under item Three of the Agenda - only available in Spanish

    Proposal of the Appointments and Compensation Committee to the Board of Directors for the appointment and re-election of independent Directors under item Three of the Agenda - only available in Spanish

    Report formulated by the Board of Directors in relation to the proposals for the appointment and re-election of Directors under item Three of the Agenda - only available in Spanish

    Annual Corporate Governance Report for fiscal year 2018

    Annual Report on Directors' Compensation for fiscal year 2018

    The Audit Committee's Report on independence of the external auditor - only available in Spanish

    2018 Operating Report by Audit Committee - only available in Spanish

    2018 Operating Report by the Appointments and Compensation Committee - only available in Spanish

    The Report of the Board of Directors of Pharma Mar, S.A. relating to the sale of Zelnova Zeltia, S.A. in favor of an investor group composed of, among others, Mr. Pedro Fernández Puentes, Director of Pharma Mar, S.A., and persons related to him - only available in Spanish

    The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - only available in Spanish

Right to information

 

    Right to information - only available in Spanish

                            Link Right to Information - only available in Spanish

Attendance, Proxy and distance voting card

 

    Attendance, Proxy and distance voting card - only available in Spanish

Online voting delegation/ Shareholders representation at General Shareholders Meeting

 

    Voting and proxy procedures and rules to representation at General Shareholders Meeting - only available in Spanish

                            On-line Voting delegation - only available in Spanish

Electronic Shareholder Forum

 

    Regulations on electronic shareholder forum - only available in Spanish

                            Electronic Sharehoder Forum - only available in Spanish

General Shareholders’ meeting broadcasting

                        General Shareholders’ meeting broadcasting

2018
Notice of call and Agenda
Shareholders’ documentation

 

  Quorum, agreements and Votes - Only available in Spanish

 Agreements - Only available in Spanish

 Proposed resolutions submitted by the Board of Directors to the decision of the General Shareholders Meeting

 Annual Financial Statements and Management Reports of Pharma Mar, S.A. and its consolidated group for fiscal year ending 31 December 2017, together with the relevant audit reports

 Identity, curriculum and category of the Directors whose appointment and or re-election is proposed to the General Meeting under item Three of the Agenda - Only available in Spanish

 Report of the Appointments and Compensation Committee justifying the proposals of the Board of Directors of the Company for the re-election of non-independent Directors under item Three of the Agenda - Only available in Spanish

 Proposal of the Appointments and Compensation Committee to the Board of Directors for the appointment and re-election of independent Directors under item Three of the Agenda - Only available in Spanish

 Report formulated by the Board of Directors in relation to the proposals for the appointment and re-election of Directors under item Three of the Agenda - Only available in Spanish

 Annual Corporate Governance Report for fiscal year 2017

 Annual Report on Directors’ Compensation for fiscal year 2017

 Appointments and Compensation Committee Report on the proposal for Pharma Mar, S.A.’s Directors’ Compensation Policy for 2019-2021- Only available in Spanish

 Pharma Mar, S.A.’s Directors’ Compensation Policy for 2019-2021

 The Audit Committee’s Report on independence of the external auditor - Only available in Spanish

 2017 Operating Report by Audit Committee - Only available in Spanish

 2017 Operating  Report by the Appointments and Compensation Committee - Only available in Spanish

 2017 corporate social responsibility report for the Pharma Mar Group

 The amendments made to the Regulations of the Board of Directors of Pharma Mar, S.A. since the last General Meeting - Only available in Spanish

 The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice - Only available in Spanish

Attendance, Proxy and distance voting card
General Shareholders' meeting broadcasting
2017
Notice of call and Agenda
Shareholders’ documentation

 

   Quorum, agreements and Votes - Only available in Spanish

  Agreements - Only available in Spanish

  Proposed resolutions submitted by the Board of Directors to the decision of the General Shareholders Meeting

  Annual Financial Statements and Management Reports of Pharma Mar, S.A. and its consolidated group for fiscal year ending 31 December 2016, together with the relevant audit reports

  Directors’ report on Agenda Item Three - Only available in Spanish

   Directors’ report on Agenda Item Four - Only available in Spanish

  Annual Corporate Governance Report for fiscal year 2016

   Annual Report on Directors’ Compensation for fiscal year 2016

   The Audit Committee’s Report on independence of the external auditor - Only available in Spanish

  2016 Operating Report by Audit Committee - Only available in Spanish

  2016 corporate social responsibility report for the Pharma Mar Group

  The amendments made to the Regulations of the Board of Directors of Pharma Mar, S.A. since the last General Meeting
Only available in Spanish

  Directors’ reports and audit report, issued by a statutory auditor other than the Company’s auditor and designated by the Mercantile Registry, in relation to the capital increases with exclusion of preemptive subscription rights agreed to by the Board of Directors on 17 May 2017, in exercise of the powers granted thereto, by virtue of Agenda Resolution Eleven of the Company’s General Meeting held on 30 June 2015, to increase share capital - Only available in Spanish

   The total number of shares and voting rights of the Company as of the publication date of this General Meeting notice
Only available in Spanish

   

Attendance, Proxy and distance voting card
General Shareholders' meeting broadcasting
2016
Notice of call and Agenda
Attendance, Proxy and distance voting card
General Shareholders' meeting broadcasting
2015 (Zeltia)
Notice of call and Agenda
Shareholders’ documentation

 

   Quorum, agreements and Votes - Only available in Spanish

  Agreements - Only available in Spanish

   Annual Accounts and management report (31/12/2014) individual and consolidated accounts, with the respective report presented by the auditor - Only available in Spanish

   Report presented by the board of directors in relation to the amendments to the Company’s bylaws (Item Three of the Agenda) - Only available in Spanish

  Report presented by the board of directors in relation to the amendments to the General Meeting Rules (Item Four of the Agenda) - Only available in Spanish

   Identity and curriculum of the directors whose reappointment is proposed to the General Meeting under Item five of the Agenda (and in the case of director corporate body, the same information in relation to the individual who is to be appointed for exercising its functions), including the category to which they belong and the proposals (Download PDF) and reports referred to in Article 529 decies of the Spanish Corporate Enterprises Act (Download PDF) - Only available in Spanish

  Report presented by the board of directors in relation to the amendments to the Board of Director Rules (Item Nine of the Agenda) - Only available in Spanish

  Report presented by the board of directors on the use made of the power delegated by the General Shareholders’ Meeting of June 12, 2013 concerning the issuance of bonds (Item Ten of the Agenda) - Only available in Spanish

  Annual corporate governance report 2014 - Only available in Spanish

  Annual Report on the Zeltia Director’s Remuneration 2014 - Only available in Spanish

   Total number of shares and voting rights on the date of call to the General Shareholders Meeting - Only available in Spanish

  Joint Merger Plan of Zeltia, S.A., as absorbed Company, and Pharma Mar S.A. Sociedad Unipersonal, as absorbing company - Only available in Spanish

   Annual Accounts and management report individual of Zeltia, S.A. and consolidated accounts for the years ending on 31 December 20122013 and 2014, with the corresponding reports presented by the auditor - Only available in Spanish

   Annual Accounts and management report individual of Pharma Mar S.A., Sociedad Unipersonal for the years ending on 31 December 20122013 and 2014, with the corresponding reports presented by the auditor - Only available in Spanish

  Merger balance sheet of Zeltia, S.A., which corresponds with the latest annual balance sheet reported as of 31 December 2014, with the respective report presented by the auditor - Only available in Spanish

  Merger balance sheet of Pharma Mar S.A., Sociedad Unipersonal, which corresponds with the latest annual balance sheet reported as of 31 December 2014, with the respective report presented by the auditor - Only available in Spanish

  Current bylaws of Zeltia, S.A. along with the text resulting from the bylaws for the case they have been adopted the amendments proposed to the General Meeting under Item Three of the Agenda - Only available in Spanish

  Current bylaws of Pharma Mar, S.A. Sociedad Unipersonal along with the text of the new bylaws of Pharma Mar, S.A. Sociedad Unipersonal including the amendments to be introduced - Only available in Spanish

  Identity of the board members of Zeltia, S.A. and Pharma Mar, S.A. Sociedad Unipersonal, and the date on which they took their positions, and, where appropriate, the same indications of those who will be proposed as directors as a result of the merger - Only available in Spanish

Shareholders representation at the General Shareholders Meeting
Attendance, Proxy and voting card

Share Information

Official Notices to the CNMV

Merger PharmaMar-Zeltia